These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 18070184

  • 1. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C.
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [Abstract] [Full Text] [Related]

  • 2. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J, Spindler KL, Ploen J, Jakobsen A.
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [Abstract] [Full Text] [Related]

  • 3. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.
    Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR.
    Cancer; 2008 Jul 01; 113(1):57-64. PubMed ID: 18442099
    [Abstract] [Full Text] [Related]

  • 4. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim TH, Chang HJ, Kim DY, Jung KH, Hong YS, Kim SY, Park JW, Oh JH, Lim SB, Choi HS, Jeong SY.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):1158-65. PubMed ID: 19800178
    [Abstract] [Full Text] [Related]

  • 5. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2766-72. PubMed ID: 17551794
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.
    Ann Surg Oncol; 2008 Oct 15; 15(10):2661-7. PubMed ID: 18389322
    [Abstract] [Full Text] [Related]

  • 9. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z, Lövey J, Hitre E, Orosz Z, Gödény M, Péley G, Sulyok Z, Rényi Vámos F, Farkas E, Köves I.
    Orv Hetil; 2006 Oct 22; 147(42):2011-20. PubMed ID: 17165600
    [Abstract] [Full Text] [Related]

  • 10. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A, Mukhopadhyay T, Ramani VS, Perkins K, Snee AJ, Jelley F, Wong H, Lee CD.
    Colorectal Dis; 2010 Aug 22; 12 Suppl 2():30-6. PubMed ID: 20618365
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW, Lim SB, Kim DY, Jung KH, Hong YS, Chang HJ, Choi HS, Jeong SY.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):810-7. PubMed ID: 19101093
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy comparison of neoadjuvant radiotherapy with or without chemotherapy for locally advanced rectal cancer].
    Wu B, Qiu HZ, Xiao Y, Lin GL, Niu BZ, Zhang FQ, Hu K.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar 01; 11(2):124-7. PubMed ID: 18344077
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
    Lee SH, Hernandez de Anda E, Finne CO, Madoff RD, Garcia-Aguilar J.
    Dis Colon Rectum; 2005 Dec 01; 48(12):2249-57. PubMed ID: 16400512
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
    Yu BM, Zhang M, Wu WQ, Chen LW, Fu J, Fei CS, Shen Y.
    Zhonghua Wai Ke Za Zhi; 2007 Apr 01; 45(7):445-8. PubMed ID: 17686297
    [Abstract] [Full Text] [Related]

  • 19. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
    Kulkarni T, Gollins S, Maw A, Hobson P, Byrne R, Widdowson D.
    Colorectal Dis; 2008 Jun 01; 10(5):479-89. PubMed ID: 18318754
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):99-107. PubMed ID: 18407433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.